Flag International United States
us/data image

Urgent ® PC Clinical Data

There are numerous publications highlighting the use of percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder, urinary urgency, urinary frequency and urge incontinence.

The Urgent PC Neuromodulation System is the only FDA-cleared system available to provide PTNS treatment. The device technology and treatment protocol are founded on the SANS device (Stoller's Afferent Nerve Stimulator).

Uroplasty recently commissioned a meta-analysis of studies highlighting the use of PTNS for the treatment of urinary urgency, urinary frequency and urge incontinence. Results of the analysis indicated that the majority of patients responded to PTNS (71%). Reductions in the number of voids, void volume and voids per night were highly significant.

The following abstracts are listed by publication year with the most recent listed first.  

Click on the article title to view the full abstract:

Search clinical data abstracts:

Efficacy of percutaneous tibial nerve stimulation in octogenarians for overactive bladder symptoms
Tenggardjaja, C., Quirouet, A., Goldman, H. (2014). Poster presentation, SUFU Winter Meeting, Miami, FL.
Percutaneous posterior tibial nerve stimulation in the treatment of overactive bladder: Long term effectiveness
Gugliotta, G., Calagna, G., Adile, G., Giunta, M., Adile, B. Poster presentation International Continence Society (Aug 2013).
Percutaneous tibial nerve stimulation results after 5 years: A cross-sectional study
Finazzi, Agro E., Bianchi, D., Diamante, C., Faralli, F., Petta, F., Iacovelli, V., Musco, S. Poster International Continence Society (Aug 2013).
Is posterior tibial nerve stimulation (PTNS) cost effective in comparison to antimuscarinic therapy? A cost comparison study in the management of overactive bladder (OAB).
Abeywickrama, L., Giarenis, I., Rantell, A., Srikrishna, S., Robinson, D., Cardozo, L. Poster International Continence Society (Aug 2013).
Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study
Vecchioli-Scaldazza, C., Morosetti, C., Berouz, A., Giannubilo, W., Ferrara, V. (2013). Gynecologic and Obstetric Investigation.
Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study
Peters, K.M., Carrico, D.J., MacDiarmid, S.A., Wooldridge, L.S., Khan, A.U., McCoy, C.E., Franco, N., Bennett, J.B. (2013) Dept of Urology Beaumont.
Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
Peters, K., Carrico, D., MacDiarmid, S., Wooldridge, L., Khan, A. et al. (2013). Neurourol Urodyn, 32(1), 24-9.
30 month study results using percutaneous tibial nerve stimulation: long term efficacy outcomes
Peters, K., Carrico, D., MacDiarmid, S., Wooldridge, L., Khan, A. (2012). Poster presentation, AUA Annual Conference, Atlanta, GA
Neurostimulation treatment for overactive bladder: an evaluation of cost effectiveness data
MacDiarmid, S., Martinson, M., Black, E. (2012). Poster presentation, AUA Annual Conference, Atlanta, GA
Percutaneous tibial nerve stimulation in the management of overactive bladder: a systematic review and meta-analysis.
Ruan, J., Dahabreh, I., Ip, S., Ferzandi, T., Wong, J. (2011). Female Pelvic Med & Reconstr Surg 17:5 supplement 2.
Reduction in urge incontinence: symptom evaluation of percutaneous tibial nerve stimulation vs. sham trial
Peters, K., Carrico, D., Perez, R., Khan, A. (2011). Poster, North Central Section of the American Urology Association Meeting, Rancho Mirage, CA
Long term treatment interval frequency of percutaneous tibial nerve stimulation: 18-month results from the STEP Study
Wooldridge, L., Carrico, D., MacDiarmid, S., Peters, K. (2011). Poster, SUNA Annual Meeting, San Antonio, TX.
Treatment interval frequency of percutaneous tibial nerve stimulation (PTNS): 18-month results from the STEP Study.
Peters, K., Carrico, D., Wooldridge, L. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
SUmiT Trial Outcomes: Clinical Insights Into Percutaneous Tibial Nerve Stimulation.
Sand, P., Peters, K., Carrico, D. (2011) International Continence Society (ICS) Annual Meeting, Glasgow, UK
Treatment interval frequency of percutaneous tibial nerve stimulation (PTNS): preliminary results from the STEP Study.
MacDiarmid, S., Peters, K., Carrico, D., & Wooldridge, L. (2011). Poster, American Urology Association Annual Meeting , Washington, DC.
Insight into percutaneous tibial nerve stimulation: critical evaluation of the SUmiT Trial.
Peters, K., Carrico, D., MacDiarmid, S., & Wooldridge, L. (2011). Poster, American Urology Association Annual Meeting, Washington, DC.
Percutaneous tibial nerve stimulation vs. validated sham in those exposed to pharmacologic therapy.
Elser, D., & McCoy, C. (2011). Presentation, American College of Obstetricians and Gynecologists Annual Clinical Meeting, Washington, DC.
Neuromodulation for the masses.
MacDiarmid, S. (2011) Presentation, Society for Urodynamics and Female Urology 2011 Winter Meeting, Phoenix, Arizona.
12 month percutaneous tibial nerve stimulation treatment interval results: outcomes from the OrBIT Trial.
MacDiarmid, S., et al. (2010). Poster, International Continence Society, Toronto, Canada.
Comparative effectiveness: percutaneous tibial nerve stimulation (PTNS) and sacral nerve stimulation (SNS) for overactive bladder (OAB) treatment.
MacDiarmid, S.A. et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
Percutaneous tibial nerve stimulation for the treatment of overactive bladder: treatment interval frequency.
MacDiarmid, S.A., et al. (2010). Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.
New efficacy data on percutaneous tibial nerve stimulation: a multi-center, randomized, sham-controlled trial for overactive bladder syndrome.
Peters, K.M., et al. (2010). Presentation, Society for Urodynamics and Female Urology, St. Petersburg, FL.
6 and 12 month results from OrBIT trial comparing percutaneous tibial nerve stimulation (PTNS) vs. extended-release tolterodine.
Peters, K., et al. (2009). Poster, International Continence Society, San Francisco, CA.
Percutaneous tibial nerve stimulation: Efficacy with patients also taking anticholinergics.
Wooldridge, L. (2009). Poster, International Continence Society, San Francisco, CA.
Percutaneous tibial nerve stimulation (PTNS): A literature-based assessment.
MacDiarmid, S.A., et al. (2009). Current Bladder Dysfunction Reports, 4, 29-33.
Long term sustained therapeutic effect of percutaneous tibial nerve stimulation in the management of Overactive Bladder.
MacDiarmid, S.A., et al. (2009). Presentation, American Urological Association Annual Meeting, Chicago, IL.
A randomized multicenter study comparing percutaneous tibial nerve stimulation with pharmaceutical therapy for the treatment of overactive bladder.
Peters, K.M., et al. (2008). Presentation, Late Breaking Science Forum, American Urological Association Annual Meeting, Orlando, FL.
Percutaneous tibial nerve stimulation: The Urgent PC device.
van Balkan, M.R. (2007). Expert Rev Med Devices, 4(5), 693-698.
Percutaneous tibial nerve stimulation (PTNS): Results at long-term follow-up.
Cappellano, F., et al. (2006). Poster, SIUD National Congress, Italy.
Posterior tibial nerve stimulation (PTNS) in the treatment of LUTS secondary to Parkinson's Disease.
Finazzi-Agrò, E., et al. (2006). Poster, SUID National Congress, Italy.
Prognostic factors for successful percutaneous tibial nerve stimulation.
van Balken, M.R., et al. (2006). Eur Urol, 49(2), 360-365.
Posterior tibial nerve stimulation in the treatment of urge incontinence.
Vandoninck, V., et al. (2003). Neuro Urodyn, 22, 17-23.
Temporary sacral and tibial neuromodulation in treating patients with overactive urinary bladder.
Mazo, E.B., & Krivoborodov, G.G. (2002). Zurnal Voprosy Nejrochirurgii Imeni NN Burdenko, 1, 17-21.
The efficacy of Stoller Afferent Nerve Stimulation in frequency/urgency syndrome: A randomised control trial.
Vohra, A.K., et al. (2002). Abstract 217, ICS 32nd Annual Meeting, Heidelberg.
Afferent nerve stimulation for pelvic floor dysfunction.
Stoller, M.L. (1999). Eur Urol, 35 (suppl 2), 16.